|
Realtime
CBOE
20:42:05 21.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 103.00 USD | +0.46% |
|
+0.54% | -18.15% |
| 18:42 | Grail legt deutlich zu, da FDA-Prüfer keine wesentlichen Bedenken zum Multi-Krebs-Test äußern | RE |
| 18.09. | Trinity Heart Experts als Erste in den Quad Cities mit neuer Afib-Technologie | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.39% | -0.26% | -11.85% | +17.07% | -17.93% | -24.74% | +3.93% | -17.83% | +145.28% | 178 Mrd. | |
| -0.10% | -2.00% | -1.53% | +15.96% | -4.31% | -2.85% | +14.24% | -28.10% | +5.49% | 118 Mrd. | |
| +2.29% | -3.11% | -0.62% | +16.51% | -6.42% | +9.45% | +70.91% | +160.14% | +280.72% | 58.92 Mrd. | |
| +0.10% | -1.17% | -5.85% | +28.47% | -6.85% | -3.10% | -31.79% | -30.20% | +0.78% | 49.29 Mrd. | |
| -0.22% | -0.37% | -10.44% | -17.03% | -4.56% | +10.27% | +42.75% | +21.76% | +458.70% | 48.17 Mrd. | |
| +0.23% | +5.47% | -3.28% | +29.31% | +34.57% | +28.49% | +0.26% | -35.49% | +282.10% | 33.72 Mrd. | |
| +0.21% | -2.76% | -7.50% | -8.70% | -24.55% | - | - | - | - | 27.76 Mrd. | |
| +0.30% | +2.16% | +2.77% | +10.06% | +31.89% | +43.87% | -3.05% | -19.02% | +384.02% | 25.5 Mrd. | |
| +1.77% | +9.57% | +4.19% | +24.52% | -4.00% | +9.06% | -13.10% | -62.37% | +206.29% | 22.1 Mrd. | |
| -2.33% | -0.36% | -13.14% | +0.61% | -1.41% | -8.97% | +7.08% | -18.14% | +128.37% | 21.03 Mrd. | |
| +0.56% | -3.94% | -13.74% | +2.42% | -19.04% | -17.80% | -6.99% | -3.24% | +178.61% | 19.99 Mrd. | |
| -0.85% | -2.19% | -6.49% | +8.43% | +5.02% | -7.18% | -19.84% | -33.85% | -25.76% | 18.19 Mrd. | |
| +0.62% | -0.58% | -0.30% | +21.40% | +12.70% | +21.07% | - | - | - | 15.12 Mrd. | |
| +0.91% | +3.24% | +3.73% | +16.11% | +18.01% | +16.26% | +104.92% | +37.08% | +347.29% | 14.81 Mrd. | |
| +0.20% | -4.17% | -13.19% | +16.30% | +19.65% | +0.24% | -40.00% | -72.10% | -52.29% | 11.79 Mrd. | |
| -1.97% | +4.79% | - | - | - | - | - | - | - | 10.5 Mrd. | |
| +0.10% | -3.78% | -9.44% | -15.28% | -5.73% | +12.22% | -50.98% | -79.24% | +54.41% | 10.49 Mrd. | |
| -0.10% | +2.02% | -1.06% | +33.75% | +24.09% | +32.69% | +5.23% | -52.13% | +134.13% | 10.01 Mrd. | |
| +1.80% | +7.32% | -0.46% | +42.44% | +10.03% | +43.16% | +11.48% | -42.62% | +439.47% | 9.98 Mrd. | |
| Durchschnitt | +0.19% | +1.35% | -4.90% | +13.46% | +3.40% | +9.54% | +5.94% | -17.21% | +185.47% | 36.99 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.29% | +0.91% | -6.00% | +13.84% | -4.00% | -1.17% | +10.86% | -5.67% | +162.63% |
- Börse
- Aktien
- 850103 Aktie
- 850103 Aktie
- Sektor Abbott Laboratories
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
